Nurse Practitioner, Family · Wichita, KS
NPI
1487060216
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1001 N Minneapolis St
Wichita, KS, 67214
Phone (316) 293-1840
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
8,353 services
Medicare patients, 2024
89
Average age 63
Drug cost, 2024
$5.0M
11,343 prescriptions
Company payments, 2025
$30K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kayla del Rio was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,321 times for 13 patients. In total Kayla del Rio billed 8,353 services in 59 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,321 | 13 | $0.09 | $116 |
| 99214 Office E&M - Established | Office | 104 | 55 | $59.48 | $6,186 |
| 96372 Injection Administration | Office | 88 | 28 | $7.66 | $674 |
| 99213 Office E&M - Established | Office | 82 | 51 | $41.16 | $3,375 |
| G0008 Administration of influenza virus vaccine | Office | 31 | 30 | $29.94 | $928 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 29 | 29 | $100.88 | $2,926 |
| 81003 Clinical Chemistry | Office | 27 | 19 | $2.20 | $59.4 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 26 | 15 | $0.78 | $20.16 |
| 83036 Blood Count | Office | 26 | 16 | $9.52 | $248 |
| 91322 Vaccine Product | Office | 23 | 22 | $156.41 | $3,597 |
| 90480 Vaccine Administration | Office | 23 | 22 | $39.83 | $916 |
| 90662 Vaccine Product | Office | 17 | 17 | $78.40 | $1,333 |
| 96127 Behavioral Health Services | Office | 13 | 13 | $3.21 | $41.73 |
| 90661 Vaccine Product | Office | 12 | 12 | $36.11 | $433 |
By year: 2022 $29K for 13,559 services; 2023 $25K for 9,012 services; 2024 $27K for 8,353 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 27 | 19 | $2.20 | $59.4 |
| 83036 Blood Count | 26 | 16 | $9.52 | $248 |
Medicare prescription drug claims, 2024
In 2024, the drug Kayla del Rio prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 493 prescriptions and refills. In total Kayla del Rio wrote 11,343 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 493 | 501 | 49 | $2.0M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 339 | 339 | 53 | $11K |
| Pantoprazole Sodium Generic | 268 | 379 | 41 | $1,119 |
| Oxycodone Hcl Generic | 261 | 261 | 25 | $5,940 |
| Atorvastatin Calcium Generic | 257 | 396 | 41 | $1,592 |
| Alprazolam Generic | 251 | 251 | 33 | $1,698 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 251 | 277 | 47 | $6,297 |
| Gabapentin Generic | 246 | 308 | 37 | $3,272 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 193 | 193 | 31 | $8,070 |
| Levothyroxine Sodium Generic | 174 | 311 | 29 | $1,352 |
| Trazodone Hcl Generic | 170 | 198 | 24 | $730 |
| Bupropion Xl Bupropion Hcl | 163 | 185 | 27 | $1,443 |
| Cyclobenzaprine Hcl Generic | 143 | 177 | 27 | $1,871 |
| Lisinopril Generic | 141 | 259 | 31 | $480 |
| Fluoxetine Hcl Generic | 135 | 141 | 16 | $697 |
Brand drugs: 2,615 claims; generic drugs: 8,648 claims; opioid claims: 1,086.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kayla del Rio $30K ($30K in general payments such as food, travel and fees) from 27 companies. The largest payer was Gilead Sciences, Inc. with $27K.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 64 | $27K |
| ViiV Healthcare Company GSK | 31 | $708 |
| Madrigal Pharmaceuticals MDGL | 2 | $257 |
| Abbott Laboratories ABT | 4 | $197 |
| Abbvie Inc. ABBV | 14 | $192 |
| Dexcom, Inc. DXCM | 2 | $144 |
| Eisai Inc. 4523.T | 2 | $141 |
| GlaxoSmithKline, LLC. GSK | 2 | $136 |
| ACADIA Pharmaceuticals Inc ACAD | 1 | $123 |
| Janssen Biotech, Inc. JNJ | 2 | $108 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.